UBS maintains a 'Neutral' on PharMerica (PMC); Q1 Preview; Is There A Hangover From OCR’s Hostile Takeover Attempt?

Go back to UBS maintains a 'Neutral' on PharMerica (PMC); Q1 Preview; Is There A Hangover From OCR’s Hostile Takeover Attempt?